This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Telmisartan and Hydrochlorothiazide

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

5

Spl Product Data Elements

Telmisartan and Hydrochlorothiazide Telmisartan and Hydrochlorothiazide TELMISARTAN TELMISARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE SILICON DIOXIDE CROSPOVIDONE FERRIC OXIDE RED HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE MANNITOL MEGLUMINE POVIDONE SODIUM HYDROXIDE SODIUM STEARYL FUMARATE SORBITOL TALC Mottled Light brown to Mottled Brown WHITE TO OFF WHITE Oblong Shaped 513 Telmisartan and Hydrochlorothiazide Telmisartan and Hydrochlorothiazide TELMISARTAN TELMISARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE SILICON DIOXIDE CROSPOVIDONE FERRIC OXIDE RED HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE MANNITOL MEGLUMINE POVIDONE SODIUM HYDROXIDE SODIUM STEARYL FUMARATE SORBITOL TALC Mottled Light brown to Mottled Brown WHITE TO OFF WHITE Oblong Shaped 514 Telmisartan and Hydrochlorothiazide Telmisartan and Hydrochlorothiazide TELMISARTAN TELMISARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE SILICON DIOXIDE CROSPOVIDONE FERRIC OXIDE RED HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE MANNITOL MEGLUMINE POVIDONE SODIUM HYDROXIDE SODIUM STEARYL FUMARATE SORBITOL TALC FERRIC OXIDE YELLOW Mottled Light brown to Mottled Brown YELLOW Oblong Shaped 515

Application Number

ANDA204221

Brand Name

Telmisartan and Hydrochlorothiazide

Generic Name

Telmisartan and Hydrochlorothiazide

Product Ndc

70771-1123

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1123-9 in bottle of 90 tablets Telmisartan and Hydrochlorthaizide Tablets USP, 40 mg/12.5 mg R x only 90 tablets NDC 70771-1124-9 in bottle of 90 tablets Telmisartan and Hydrochlorthaizide Tablets USP, 80 mg/12.5 mg R x only 90 tablets NDC 70771-1125-9 in bottle of 90 tablets Telmisartan and Hydrochlorthaizide Tablets USP, 80 mg/25 mg R x only 90 tablets Telmisartan HCTZ Tablet Telmisartan HCTZ Tablet Telmisartan HCTZ Tablet

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.